- Hepatitis research and development timeline
- Hepatitis C Virus patent assignments: patents with HCV in the patent claim
- KEI Policy Brief: Non-Voluntary use of HCV patents in the United States
- SCCR28: Chair’s Conclusions (No recommendations on broadcasting or limitations and exceptions for libraries and archives)
- Gilead in 2013: AbbVie sought to eliminate competition and dominate market for HCV drugs
- KEI asks FTC to investigate Shire decision to abandon efforts to compete in US market for Fabry’s disease treatments
- New UK Parliamentary report on Global TB urges the United Kingdom to explore a WTO Agreement on the Provision of Public Goods
- US Court issues compulsory license for know-how protected as trade secret
- Senators Wyden and Grassley launch investigation of pricing of Sovaldi, treatment for Hepatitis C Virus
- 28 October 2014: WTO Innovation Fair on the margins of WTO TRIPS Council review of the Paragraph 6 system
The graph below reports the ratio of deaths to new cases of tuberculosis in 2004, in WHO "regions by income."
The following graph reports the ratio of DALYs to Prevelance for Asthma in 2004, with countries groups in WHO regions by income.
A pdf version of this document is available here.
KEI Research Note 2010:5
December 23, 2010
Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region
Cancer: Annual deaths compared to new cases in 2004, for 16 types of cancer and 4 World Bank income groupsSubmitted by James Love on 21. December 2010 - 10:21
The following table compares the annual deaths from cancer, to the annual incidence of the disease, broken down by cancer type and income group. The data in the table is annual deaths divided by annual incidence, show as a ratio.
For several types of cancer, there is not much difference in the reported ratios, between different income groups. For other types of cancer, the differences are large, and in favor of patients living in higher income countries. Cancer types with the largest disparities by income include the following:
- Mouth and oropharynx cancers
Ratio of year 2000 breast cancer deaths to new breast cancer patients in Europe, by country and country incomeSubmitted by James Love on 21. December 2010 - 8:37
The following graph presents the year 2000 raw mortality rate of breast cancer patients in 36 European Countries. The graph compares the ratio of breast cancer deaths to the annual incidence of breast cancer, to the per capita incomes in those countries, all based upon year 2000 data.
USTR has issued a request for comments on ACTA. The deadline for submissions is February 15, 2011. The notice gives very little guidance regarding the issues the USTR would like addressed in the comments.
[Billing Code 3190-W1-P]
Office of the United States Trade Representative
Anti-Counterfeiting Trade Agreement: Request for Comments from the Public
Agency: Office of the United States Trade Representative
Action: Request for written submissions from the public
Today USTR provided some additional insight into negotiations of a regional, Asia-Pacific trade agreement, known as the Trans-Pacific Partnership (TPP) Agreement. The USTR web page on the TPP negotiations is http://www.ustr.gov/tpp. At present, the TPP negotiators include Australia, Brunei Darussalam, Chile, New Zealand, Peru, Singapore and Vietnam. Japan and Canada have expressed interest in joining the negotiations, and USTR clearly would like to design an agreement that will be open to other countries. Our discussions focused on the intellectual property chapter in the agreement.
Development Agenda committee mandates WIPO to examine Bolivia, Barbados, Suriname and Bangladesh prize proposalsSubmitted by thiru on 13. December 2010 - 7:14
On Friday, 26 November 2010, the 6th session of the WIPO Committee on Development Agenda and Intellectual Property approved a project entitled "Project on Open Collaborative Projects and IP-Based Models". As mentioned in KEI's previous posting on this subject, this project endeavors to implement Recommendation 36 of the Development Agenda which states:
13 December 2010
Drug Name(s) HERCEPTIN (Brand Name Drug)
FDA Application No. (BLA) 103792
Active Ingredient(s) TRASTUZUMAB
Company GENENTECH (Roche acquired a majority ownership in 1990, and full ownership in March 2009.)
Original Approval or Tentative Approval Date September 25, 1998
What is Herceptin? How does it work?
For background on the Fabrazyme case, see: http://www.keionline.org/fabrazyme
The following statements were made today by civil society on the NIH rejection of the Fabrazyme March-in Request Petition. Contact Judit Rius at email@example.com if your organization would like to submit an statement.
Statement by James Love, Director of Knowledge Ecology International (KEI) (Contact: 1.202.361.3040)
CDIP6: Bolivia's intervention on WIPO's proposed project on 'Open Collaborative Projects and IP-Based Models'Submitted by thiru on 25. November 2010 - 5:51
25 November 2010
The fourth day of WIPO's Committee on Development and Intellectual Property(CDIP6) has witnessed a rich discussion on how to implement Recommendation 36 of the WIPO Development Agenda which states:
Recommendation 36 (Cluster D): To exchange experiences on open collaborative projects such as the Human Genome Project as well as on intellectual property models
KEI statement to Committee on Development and Intellectual Property on WIPO project on IP and Competition PolicySubmitted by thiru on 24. November 2010 - 9:43
Knowledge Ecology International made the following intervention today at the 6th Session of the WIPO Committee on Development and Intellectual Property (CDIP).
KEI statement to WIPO CDIP 6 on Agenda item 5
Thank you Ambassador and congratulations on your appointment as Chair of this Committee.
Revealing study by L Yager (GAO): 'Observations on efforts to quantify the economic effects of counterfeit and pirated goods'Submitted by thiru on 24. November 2010 - 6:01
The 6th session of the WIPO Advisory Committee on Enforcement is taking place in Geneva from 1-2 December 2010. KEI's observations on the 5th session, entitled, Positive outcome reached at WIPO Advisory Committee on Enforcement while ACTA looms in the East can be found here:http://keionline.org/node/681.